Fig. 2: Modification of ER, PR and HER2 status between primary tumour and metastasis. | npj Breast Cancer

Fig. 2: Modification of ER, PR and HER2 status between primary tumour and metastasis.

From: Phenotypic discordance between primary and metastatic breast cancer in the large-scale real-life multicenter French ESME cohort

Fig. 2

a Hormone receptor status on primary tumour and metastasis (n = 1566), b HER2 status on primary tumour and metastasis (n = 1076), c Estrogen receptor status on primary tumour and metastasis (n = 1557), d Progesterone receptor status on primary tumour and metastasis (n = 1461). HR Hormone receptor expression, HER2 human epidermal growth factor receptor 2, ER Estrogen receptor expression, PR Progesterone receptor expression.

Back to article page